ANDA 61667, held by Ani Pharms. Vancomycin Hydrochloride.
As of Nov 16, 2026, ANDA 61667 (Vancocin Hydrochloride), held by Ani Pharms, was first approved by FDA on Jul 13, 1983, with 8 approved supplements and 0 published complete response letters.
| Date | Submission | Status | Documents |
|---|---|---|---|
| Jul 13, 1983 | Original application | Approved |
| Vancocin HydrochlorideEQ 500MG BASE/6ML · for solution;oral | Vancomycin Hydrochloride | Discontinued |
| Vancocin HydrochlorideEQ 250MG BASE/5ML · for solution;oral | Vancomycin Hydrochloride | Rx |
| Jan 29, 2021 | Supplement 27Labeling · Standard review | Approved | None posted |
| Jan 29, 2021 | Supplement 28Labeling · Standard review | Approved | None posted |
| Jun 20, 2019 | Supplement 26Labeling · Standard review | Approved | |
| Sep 9, 1997 | Supplement 23Labeling | Approved | None posted |
| Jun 20, 1996 | Supplement 21Manufacturing | Approved | None posted |
| Jul 29, 1993 | Supplement 20Labeling | Approved | None posted |
| Jul 12, 1991 | Supplement 17Labeling | Approved | None posted |
| May 17, 1991 | Supplement 14Labeling | Approved | None posted |
| Jul 13, 1983 | Original application | Approved |
Approvals, supplements, products and documents come from FDA's Drugs@FDA data files, refreshed daily; Drugs@FDA lists approved applications only. Complete response letters are FDA's published letters. Drugs@FDA and FDA complete response letters